A Study Evaluating Potential Disease-Mediated Drug-Drug Interaction in Adult Participants With Active Eosinophilic Esophagitis Receiving Cendakimab
Condition(s):Eosinophilic EsophagitisLast Updated:February 16, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Eosinophilic EsophagitisLast Updated:February 16, 2024Recruiting
Condition(s):Dysphagia; Lung Cancer; Pain; EsophagitisLast Updated:August 31, 2017Completed
Condition(s):Reflux EsophagitisLast Updated:July 10, 2014Completed
Condition(s):Eosinophilic EsophagitisLast Updated:April 26, 2023Completed
Condition(s):Eosinophilic EsophagitisLast Updated:March 15, 2024Recruiting
Condition(s):Eosinophilic Esophagitis (EoE)Last Updated:October 9, 2019Completed
Condition(s):Gastroesophageal Reflux Disease; Reflux EsophagitisLast Updated:June 27, 2011Completed
Condition(s):Eosinophilic EsophagitisLast Updated:October 21, 2022Completed
Condition(s):Eosinophilic EsophagitisLast Updated:October 26, 2023Completed
Condition(s):Gastroesophageal Reflux Disease; Minimal Change Disease; Non-Reflux EsophagitisLast Updated:September 19, 2017Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.